Transcriptomic Portraits and Molecular Pathway Activation Features of Adult Spinal Intramedullary Astrocytomas.

RNA sequencing (RNA-seq) gene expression glioblastoma molecular pathway activation spinal cord neoplasms spinal intramedullary astrocytoma transcriptomic (RNA-Seq)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 16 12 2021
accepted: 21 02 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

In this study, we report 31 spinal intramedullary astrocytoma (SIA) RNA sequencing (RNA-seq) profiles for 25 adult patients with documented clinical annotations. To our knowledge, this is the first clinically annotated RNA-seq dataset of spinal astrocytomas derived from the intradural intramedullary compartment. We compared these tumor profiles with the previous healthy central nervous system (CNS) RNA-seq data for spinal cord and brain and identified SIA-specific gene sets and molecular pathways. Our findings suggest a trend for SIA-upregulated pathways governing interactions with the immune cells and downregulated pathways for the neuronal functioning in the context of normal CNS activity. In two patient tumor biosamples, we identified diagnostic

Identifiants

pubmed: 35387112
doi: 10.3389/fonc.2022.837570
pmc: PMC8978956
doi:

Types de publication

Journal Article

Langues

eng

Pagination

837570

Informations de copyright

Copyright © 2022 Konovalov, Timonin, Asyutin, Raevskiy, Sorokin, Buzdin and Kaprovoy.

Déclaration de conflit d'intérêts

Author MR was employed by Omicsway Corp and AB was employed by Omicsway Corp. and Oncobox Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Anticancer Res. 2007 Jul-Aug;27(4C):2729-36
pubmed: 17695439
Cancers (Basel). 2019 Sep 18;11(9):
pubmed: 31540406
BMC Med Genomics. 2020 Sep 18;13(Suppl 8):111
pubmed: 32948183
Sci Rep. 2016 Feb 03;6:20567
pubmed: 26837275
Nat Med. 2019 May;25(5):751-758
pubmed: 31011205
J Clin Oncol. 2008 Oct 1;26(28):4659-65
pubmed: 18824712
Biosci Rep. 2017 Mar 27;37(2):
pubmed: 28232512
Cancers (Basel). 2021 Jul 08;13(14):
pubmed: 34298634
Cancer Med. 2016 Aug;5(8):1947-9
pubmed: 27264843
Dev Neurorehabil. 2018 Aug;21(6):415-422
pubmed: 28968151
Sci Rep. 2020 Sep 23;10(1):15534
pubmed: 32968196
Neurosurg Clin N Am. 2020 Apr;31(2):237-249
pubmed: 32147015
J Neuropathol Exp Neurol. 2010 Jun;69(6):582-92
pubmed: 20467333
Mol Ther. 2021 Aug 4;29(8):2583-2600
pubmed: 33794365
Anticancer Drugs. 2014 Jul;25(6):723-8
pubmed: 24441743
Genome Biol. 2019 Oct 21;20(1):213
pubmed: 31639029
Elife. 2020 Jun 26;9:
pubmed: 32589144
Cancer Biol Ther. 2011 Jan 15;11(2):254-62
pubmed: 21088499
J Neurosurg Spine. 2021 Aug 13;:1-12
pubmed: 34388706
Bioinformatics. 2021 Feb 20;:
pubmed: 33609102
J Neurooncol. 2019 Sep;144(2):359-368
pubmed: 31292802
J Pediatr Hematol Oncol. 2003 Aug;25(8):644-8
pubmed: 12902920
Cancer Manag Res. 2013 Aug 30;5:293-9
pubmed: 24039448
J Neurooncol. 2013 Jan;111(2):205-12
pubmed: 23184145
Genome Biol. 2014;15(12):550
pubmed: 25516281
Heliyon. 2021 Mar 11;7(3):e06394
pubmed: 33748471
Oncotarget. 2014 Oct 30;5(20):10198-205
pubmed: 25415353
Biochemistry (Mosc). 2020 Jul;85(7):758-772
pubmed: 33040720
Tumour Biol. 2014 Jun;35(6):5877-83
pubmed: 24719188
PLoS One. 2017 Jun 5;12(6):e0178593
pubmed: 28582410
J Neurosurg Spine. 2010 Feb;12(2):144-53
pubmed: 20121348
Biomedicines. 2020 Mar 23;8(3):
pubmed: 32210001
J Neurooncol. 2012 Oct;110(1):111-8
pubmed: 22832897
Oncotarget. 2015 Oct 6;6(30):29347-56
pubmed: 26320181
PLoS One. 2014 Apr 23;9(4):e95628
pubmed: 24759734
Science. 2020 Sep 11;369(6509):1318-1330
pubmed: 32913098
Acta Neuropathol Commun. 2016 May 27;4(1):54
pubmed: 27229157
Neuropathol Appl Neurobiol. 2011 Dec;37(7):803-6
pubmed: 21696415
Front Genet. 2014 Mar 25;5:55
pubmed: 24723936
Neurosurgery. 2005 May;56(5):972-81; discussion 972-81
pubmed: 15854245
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
J Neurooncol. 2010 May;98(1):83-92
pubmed: 19898743
Cancer Chemother Pharmacol. 2021 Jun;87(6):827-842
pubmed: 33688998
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Pediatr Blood Cancer. 2021 Feb;68(2):e28756
pubmed: 33025730
Neuro Oncol. 2015 Mar;17(3):372-82
pubmed: 25140038
Bioinformatics. 2012 Nov 1;28(21):2782-8
pubmed: 22923299
Acta Neuropathol Commun. 2021 Jun 30;9(1):119
pubmed: 34193285
Cancers (Basel). 2020 Feb 24;12(2):
pubmed: 32102350
Cureus. 2019 Jul 26;11(7):e5247
pubmed: 31565645
J Cell Biochem. 2013 Aug;114(8):1890-900
pubmed: 23494858
Oncology. 2015;88(3):173-9
pubmed: 25427949
Oper Neurosurg (Hagerstown). 2022 Mar 1;22(3):106-114
pubmed: 35030157
J Cancer Res Clin Oncol. 2019 Apr;145(4):1037-1042
pubmed: 30820715
Chin J Cancer. 2013 Nov;32(11):594-603
pubmed: 24206917
Pediatr Blood Cancer. 2012 Oct;59(4):642-7
pubmed: 22147414
Methods Mol Biol. 2020;2063:189-206
pubmed: 31667772
Cell Cycle. 2017 Oct 2;16(19):1810-1823
pubmed: 28825872
Nat Commun. 2016 Nov 16;7:13427
pubmed: 27848968
BMC Bioinformatics. 2019 Feb 6;20(1):66
pubmed: 30727942
J Natl Cancer Inst. 2004 Jan 7;96(1):46-55
pubmed: 14709738
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):727-33
pubmed: 18687533
Cancer Treat Res Commun. 2021;26:100263
pubmed: 33338858
Front Genet. 2021 Feb 09;12:617059
pubmed: 33633781
Methods Mol Biol. 2020;2063:235-255
pubmed: 31667774
Semin Cancer Biol. 2018 Dec;53:110-124
pubmed: 29935311
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Oncotarget. 2016 Oct 18;7(42):68909-68920
pubmed: 27634898
Pediatr Blood Cancer. 2004 Nov;43(6):629-32
pubmed: 15390309
J Neurooncol. 2017 Feb;131(3):603-610
pubmed: 27853960
J Neuropathol Exp Neurol. 2018 Jun 1;77(6):437-442
pubmed: 29718398
Bioinformatics. 2008 May 1;24(9):1154-60
pubmed: 18325927
Semin Cancer Biol. 2020 Feb;60:311-323
pubmed: 31412295
Neuro Oncol. 2010 Aug;12(8):855-61
pubmed: 20200024
Sci Data. 2019 Apr 23;6(1):36
pubmed: 31015567
Clin Cancer Res. 2011 Jul 15;17(14):4790-8
pubmed: 21610142
J Clin Oncol. 2000 Feb;18(4):708-15
pubmed: 10673511
Ann Clin Transl Neurol. 2020 Apr;7(4):429-436
pubmed: 32293798
Cold Spring Harb Mol Case Stud. 2021 Aug 2;7(4):
pubmed: 34341009
Oncoimmunology. 2018 Jul 30;7(9):e1468953
pubmed: 30357053
Sci Rep. 2019 Dec 10;9(1):18722
pubmed: 31822682
Br J Neurosurg. 2021 Oct 7;:1-7
pubmed: 34615413
J Neurooncol. 2015 Jan;121(2):297-302
pubmed: 25338318
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Hum Genome Var. 2015 Apr 02;2:15009
pubmed: 27081524
J Clin Oncol. 2007 Nov 20;25(33):5321-4
pubmed: 18024879
Neuro Oncol. 2015 Jul;17(7):910-1
pubmed: 25964312
Br J Cancer. 2020 Aug;123(4):568-579
pubmed: 32457362
Ann Clin Lab Sci. 2020 Jul;50(4):474-480
pubmed: 32826244
Neuro Oncol. 2014 Oct;16(10):1408-16
pubmed: 24803676
Front Oncol. 2019 Jul 17;9:658
pubmed: 31380288

Auteurs

Nikolay Konovalov (N)

Burdenko Neurosurgical Center, Moscow, Russia.

Stanislav Timonin (S)

Burdenko Neurosurgical Center, Moscow, Russia.

Dmitry Asyutin (D)

Burdenko Neurosurgical Center, Moscow, Russia.

Mikhail Raevskiy (M)

Omicsway Corp., Walnut, CA, United States.
Moscow Institute of Physics and Technology, Moscow, Russia.
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Maxim Sorokin (M)

Moscow Institute of Physics and Technology, Moscow, Russia.
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Anton Buzdin (A)

Omicsway Corp., Walnut, CA, United States.
Moscow Institute of Physics and Technology, Moscow, Russia.
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Oncobox Ltd., Moscow, Russia.

Stanislav Kaprovoy (S)

Burdenko Neurosurgical Center, Moscow, Russia.

Classifications MeSH